Catholic Health, GE HealthCare announce $500M, 10-year tech partnership
Catholic Health and GE HealthCare announced a 10-year strategic partnership valued at approximately $500 million, aimed at expanding access to advanced imaging, diagnostics and artificial intelligence-enabled technology across the Long Island-based health system. The agreement, known as a Care Alliance, will bring more than 1,300 pieces of new technology to Catholic Health’s hospitals and outpatient. . . Read More
Catholic HealthandGE HealthCareannounced a 10-year strategic partnership valued at approximately $500 million, aimed at expanding access to advanced imaging, diagnostics and artificial intelligence-enabled technology across the Long Island-based health system. The agreement, known as a Care Alliance, will bring more than 1,300 pieces of new technology to Catholic Health’s hospitals and outpatient locations, with roughly half of the equipment arriving during the first three years. Officials called it one of the largest such partnerships GE HealthCare has established with a U. S. health system. The modernization effort will focus on four service lines: cardiology, oncology, neurology and women’s health. Plans include extending advanced cardiac imaging to more outpatient sites, adding MR, CT and PET scanners equipped with on-device AI to speed the path from diagnosis to treatment, expanding nuclear medicine capabilities at St. Francis Hospital & Heart Center and Good Samaritan University Hospital, and adding hundreds of ultrasound systems. The partnership will also include an embedded cardiovascular scientist who will work directly with Catholic Health clinicians to inform future equipment decisions. “This Care Alliance represents an important investment in the future of health care on Long Island and reflects Catholic Health’s commitment to innovating in ways that improve how care is delivered,” said Gary Havican, Catholic Health’s interim president and CEO and chief operating officer in a press release. He said the partnership gives physicians and care teams “a meaningful voice in shaping the future of care so innovation is guided by real clinical and patient needs. ”Rachel Gilbreath, GE HealthCare’s region president for the East in the Unitd States and Canada, said the companies would work to integrate AI, cloud and software tools across the system over the next decade. “Together, we are aligning people, process and technology to deliver measurable impact for patients and clinicians,” she said. Catholic Health said patients could begin seeing benefits within the first year, including new contrast-enhanced mammography for breast imaging and biopsy services, additional diagnostic imaging across several modalities, and upgraded maternal-infant monitoring technology at Good Samaritan University Hospital. Beyond new equipment, the agreement includes a 10-year, multivendor service contract covering maintenance and lifecycle management across more than 40 Catholic Health sites, along with staff training. Catholic Health said the arrangement is structured to generate capital savings compared with traditional equipment purchases, potentially freeing up resources for further technology investment and program growth. The partnership also incorporates GE HealthCare’s Imaging 360 platform, a cloud-based system designed to centralize radiology workflows and performance data and enable remote scanning support across multiple sites. Sites expected to receive expanded capabilities over the course of the agreement include St. Francis Hospital & Heart Center, Good Samaritan University Hospital and its St. Charles campus, St. Joseph Hospital, St. Catherine of Siena Hospital, Mercy Hospital, and 36 additional locations. New equipment will span CT, PET/CT, nuclear medicine, MR, mammography, X-ray, surgical, ultrasound, women’s health, anesthesia, diagnostic cardiology and maternal-infant care technology. The announcement builds on an existing relationship between the two organizations. Catholic Health was an early adopter of GE HealthCare’s PET imaging agent Flyrcado, and St. Francis Hospital & Heart Center became the first site in the U. S. to perform an exercise stress PET myocardial perfusion imaging study using the agent in April 2025.